| Zhao, Shuping |
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes |
|
|
| Active, not recruiting | 3 | 408 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | T2DM (Type 2 Diabetes Mellitus) | 03/25 | 09/25 | | |
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 551 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | Type 2 Diabetes Mellitus | 03/25 | 12/25 | | |
| Zhang, Qunsheng |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
| Zhang, Xuxia |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
| Pan, Tianrong |
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes |
|
|
| Recruiting | 3 | 424 | RoW | Victoza®., Metformin Hydrochloride, TQZ2451 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Type 2 Diabetes | 12/21 | 12/21 | | |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 551 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | Type 2 Diabetes Mellitus | 03/25 | 12/25 | | |
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 318 | RoW | HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Type 2 Diabetes | 04/25 | 04/25 | | |
NCT06606483: A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight |
|
|
| Not yet recruiting | 2 | 300 | RoW | MDR-001, Placebo | MindRank AI Ltd | Obesity, Overweight and Obesity | 07/25 | 09/25 | | |
| Liu, Na |
NCT04859621: Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections |
|
|
| Recruiting | 2 | 150 | RoW | Vitamin D3 4000 IU, Vitamin D3 2000 IU, Placebo, standard antibiotic therapy | Zensun Sci. & Tech. Co., Ltd. | Recurrent Urinary Tract Infection | 04/25 | 07/25 | | |
NCT04668534: Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Functional Dyspepsia |
|
|
| Recruiting | N/A | 300 | RoW | taVNS 10, taVNS 25, Control | Air Force Military Medical University, China | Functional Dyspepsia | 12/21 | 03/22 | | |
NCT05513040: Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment |
|
|
| Recruiting | N/A | 300 | RoW | | Air Force Military Medical University, China | Functional Dyspepsia | 03/25 | 06/25 | | |
NCT05503940: Association of Multiple Medications With the Severity of Dyspepsia |
|
|
| Recruiting | N/A | 600 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
NCT06756139: Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia |
|
|
| Recruiting | N/A | 88 | RoW | cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets | Air Force Military Medical University, China, Xi'an 986 Hospital, Shaanxi Second People's Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Tang-Du Hospital, Hainan People's Hospital | Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug | 11/25 | 11/25 | | |
| Recruiting | N/A | 500 | RoW | ALF, SALF, ACLF | First Affiliated Hospital Xi'an Jiaotong University | Liver Failure | 12/24 | 12/28 | | |
NCT05841225: the Relationship Between Executive Function and Diet Adherence in Patients With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | N/A | 436 | NA | Food-related inhibitory control training based on computer, Non-food-related inhibitory control training based on computer | Na Liu | Type 2 Diabetes Mellitus | 12/24 | 12/25 | | |
NCT05527496: Effect of Hp Infection on the Quality of Gastric Mucosa Preparation |
|
|
| Recruiting | N/A | 200 | RoW | | Second Affiliated Hospital of Xi'an Jiaotong University | Helicobacter Pylori Infection | 08/23 | 08/23 | | |
NCT05524675: The Effect of Multiple Medications on the Incidence of Organic Dyspepsia |
|
|
| Recruiting | N/A | 500 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
| Wang, Yifei |
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C |
|
|
| Recruiting | 2/3 | 520 | RoW | HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo | Sunshine Lake Pharma Co., Ltd. | Chronic HCV Infection | 04/23 | 04/23 | | |
| Dong, Yaowu |
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) |
|
|
| Recruiting | 3 | 510 | Europe, Canada, Japan, US, RoW | LY3650150, Placebo, Standard therapy for INCS | Eli Lilly and Company | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 11/25 | 10/26 | | |
NCT06046391: Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult |
|
|
| Recruiting | 2 | 180 | RoW | LP-003 dose 1, LP-003 dose 2, Placebo | Longbio Pharma | Seasonal Allergic Rhinitis | 07/24 | 12/24 | | |
| Zhang, Lianhuan |
| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
